This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: European Molecular Biology Laboratory, Massachusetts Institute of Technology. Active years: 2020.
Company Filing History:
1 out of 79 
1 out of 8,576 
Years Active: 2020
Title: Jan Korbel: Innovator in Adipocyte Energy Regulation
Introduction
Jan Korbel is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of adipocyte energy consumption regulation. His innovative work focuses on understanding and manipulating the pathways that govern energy consumption in adipocytes, which are crucial for addressing obesity and related disorders.
Latest Patents
Jan Korbel holds a patent titled "Compositions and methods for manipulation of adipocyte energy consumption regulatory pathway." This patent outlines a pathway for regulating adipocyte energy consumption involving ARID5B, the genetic variant rs1421085, IRX3, and IRX5. The patent provides compositions and methods for modulating this pathway both in vitro and in vivo, aiming for anti-cachectic and anti-obesity effects. Additionally, it includes methods for identifying subjects at risk of developing disorders linked to dysregulation of the energy consumption pathway.
Career Highlights
Throughout his career, Jan Korbel has worked with prestigious institutions such as the Massachusetts Institute of Technology and the European Molecular Biology Laboratory. His research has significantly advanced the understanding of energy regulation in adipocytes, contributing to potential therapeutic approaches for obesity and related conditions.
Collaborations
Jan Korbel has collaborated with notable researchers, including Manolis Kellis and Melina Christine Claussnitzer. These collaborations have further enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Jan Korbel's innovative contributions to the field of adipocyte energy regulation highlight his role as a key inventor in addressing obesity and related disorders. His patent and collaborative efforts reflect a commitment to advancing scientific knowledge and potential therapeutic solutions.